AUTHOR=Frontiers Production Office  

TITLE=Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

JOURNAL=Frontiers in Pharmacology

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1092147

DOI=10.3389/fphar.2022.1092147

ISSN=1663-9812